Dose-response relationship between risk factors and incidence of COVID-19 in 325 hospitalized patients: A multicenter retrospective cohort study

doi:10.12998/wjcc.v10.i10.3047

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3307)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

174

WORD

HTML

1520

Figures (1-2)

206

Tables (1-6)

246

Sum=2200

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

322

Download

785

Sum=1107

Apr 6, 2022 (publication date) through Sep 8, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Cases. Apr 6, 2022; 10(10): 3047-3059
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3047

Table 3 The computed tomography score of the pulmonary involvement in four stages

	Stage-1 (n = 157)	Stage-2 (n = 194)	Stage-3 (n = 165)	Stage-4 (n = 211)	Stage-5 (n = 204)	Stage-6 (n = 137)	P value
Total CT score of the pulmonary involvement	2 ± 4 (0-18)	5 ± 5 (0-22)	7 ± 7 (0-22)	7 ± 7 (0-25)	5 ± 7 (0-24)	4 ± 6 (0-25)	< 0.0001¹
Number of involved lobes	22 ± 2 (0-5)	3 ± 2 (1-5)	4 ± 2 (1-5)	3 ± 2 (1-5)	3 ± 2 (1-5)	4 ± 2 (1-5)	< 0.0001¹
CT score in each lobe							< 0.0001¹
Left upper lobe	0 ± 1 (0-3)	1 ± 2 (0-5)	1 ± 2 (0-5)	1 ± 2 (0-5)	1 ± 2 (0-4)	1 ± 1 (0-5)
Left lower lobe	1 ± 1 (0-5)	1 ± 2 (0-5)	2 ± 2 (0-5)	2 ± 1 (0-5)	1 ± 2 (0-5)	1 ± 2 (0-5)
Right upper lobe	0 ± 1 (0-3)	1 ± 2 (0-5)	1 ± 2 (0-5)	1 ± 2 (0-5)	1 ± 2 (0-5)	1 ± 2 (0-5)
Right middle lobe	0 ± 1 (0-3)	1 ± 1 (0-5)	1 ± 2 (0-5)	1 ± 2 (0-5)	1 ± 1 (0-5)	0 ± 1 (0-5)
Right lower lobe	1 ± 2 (0-12)	2 ± 1 (0-5)	2 ± 2 (0-5)	1 ± 2 (0-5)	1 ± 1 (0-5)	1 ± 1 (0-5)

Quantitative data were presented as mean ± SD (minimum-maximum). Mann-Whitney U test showed significant difference between Stage-1 and Stage-2-6 (P < 0.05); Wilcoxon test showed significant difference between the left lower lobe and the left upper lobe (P < 0.05); Wilcoxon test showed significant difference between the right lower lobe and the right upper/middle lobe (P < 0.05).

¹P < 0.05 by t test.

CT: Computed tomography.

Citation: Zhao SC, Yu XQ, Lai XF, Duan R, Guo DL, Zhu Q. Dose-response relationship between risk factors and incidence of COVID-19 in 325 hospitalized patients: A multicenter retrospective cohort study. World J Clin Cases 2022; 10(10): 3047-3059
URL: https://www.wjgnet.com/2307-8960/full/v10/i10/3047.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i10.3047